Subtype
Malignant Reproductive System Neoplasm
CI-CAN-00001172Explore in graph →
2,804 active trials38 approved drugs186 evidence items
- NCIt
- C36076
Loading cancer entity…
Loading cancer entity…
Subtype
CI-CAN-00001172Explore in graph →
Clinical trials
12,158 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (1,473)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT03547375 | Clinical Study of Apatinib in the Treatment of Advanced Ovarian Cancer After the Failure of Standard Chemotherapy | unknown | Phase 2 | 69 | Anhui Provincial HospitalOTHER_GOV | 0 | Jun 6, 2018 | clinicaltrials |
| NCT03538704 | Effect of Fertility-sparing Therapy of Early Endometrial Cancer(ECFerSp) | unknown | N/A | 80 | Peking University People's HospitalOTHER | 1 | May 29, 2018 |
| NCT03539328 | Study on MK-3475 Plus Chemotherapy Versus Chemotherapy Alone in Recurrent, Platinum-resistant Ovarian Cancer(MITO27) | unknown | Phase 2 | 138 | Fondazione IRCCS Istituto Nazionale dei Tumori, MilanoOTHER | 1 | May 29, 2018 | clinicaltrials |
| NCT03399344 | Clinical Impact of Dedicated MR Staging of Ovarian Cancer(MRStagingOC) | unknown | N/A | 270 | The Netherlands Cancer InstituteOTHER | 1 | May 22, 2018 | clinicaltrials |
| NCT03516045 | A Study of 18F-AlF-NOTA-Neurotensin PET/CT for Imaging Prostate Cancer | unknown | Phase 1 / Phase 2 | 65 | Xiangya Hospital of Central South UniversityOTHER | 1 | May 17, 2018 | clinicaltrials |
| NCT03525652 | Therapeutic Vaccine Plus PD-1 Knockout in Prostate Cancer Treatment | unknown | Phase 1 / Phase 2 | 30 | The First Affiliated Hospital of Guangdong Pharmaceutical UniversityOTHER | 1 | May 16, 2018 | clinicaltrials |
| NCT03526809 | Molecular Imaging and Spectroscopy With Stable Isotopes in Oncology and Neurology(MISSION-ovary) | unknown | — | 40 | Cambridge University Hospitals NHS Foundation TrustOTHER | 1 | May 16, 2018 | clinicaltrials |
| NCT03509168 | The Efficacy and Safety of Preoperative Misoprostol in Blood-loss Reduction During Myomectomy.(MM) | unknown | Phase 2 / Phase 3 | 46 | Makerere UniversityOTHER | 1 | Apr 30, 2018 | clinicaltrials |
| NCT03507595 | Evaluation of the Metastasis and Recurrence of Prostate Cancer | unknown | — | 400 | Xinhua Hospital, Shanghai Jiao Tong University School of MedicineOTHER | 1 | Apr 25, 2018 | clinicaltrials |
| NCT02294903 | Focal Prostate Radiofrequency Ablation(ProRAFT) | unknown | N/A | 20 | Trod Medical N.V.INDUSTRY | 1 | Apr 24, 2018 | clinicaltrials |
| NCT02879214 | Simultaneously Integrated Dose Escalation for Locally Advanced Cervical Cancer(Side) | unknown | Phase 2 | 50 | Sichuan Provincial People's HospitalOTHER | 1 | Apr 18, 2018 | clinicaltrials |
| NCT03500367 | Efficacy and Safety of Rapamycin (Sirolimus) in the Treatment of Symptomatic Uterine Fibroids and Leiomyomatosis | unknown | Phase 4 | 25 | Peking Union Medical College HospitalOTHER | 1 | Apr 18, 2018 | clinicaltrials |
| NCT01890096 | A Phase II Trial of High Dose-Rate Brachytherapy as Monotherapy in Low and Intermediate Risk Prostate Cancer | unknown | Phase 2 | 174 | Sunnybrook Health Sciences CentreOTHER | 1 | Apr 17, 2018 | clinicaltrials |
| NCT03496142 | Perineal Versus Rectal Approach for Prostate Biopsy to Prevent Iatrogenic Infections(PRAPI) | unknown | N/A | 340 | Institut Mutualiste MontsourisOTHER | 1 | Apr 12, 2018 | clinicaltrials |
| NCT03488706 | Assessing Circulating Tumor Cell as a Biomarker for Prostate Cancer Detection in Patients With Gray Zone PSA Level | unknown | — | 500 | CellMaxLifeINDUSTRY | 1 | Apr 5, 2018 | clinicaltrials |
| NCT02313298 | Stereotactic Body Radiotherapy for Organ Confined Prostate Cancer | unknown | Phase 2 | 80 | National Cancer Centre, SingaporeOTHER | 1 | Mar 29, 2018 | clinicaltrials |
| NCT03188159 | Vinorelbine in Relapsed Platinum Resistant or Refractory C5 High Grade Serous, Endometrioid, or Undifferentiated Primary Peritoneum, Fallopian Tube or Ovarian Cancer | unknown | Phase 2 | 36 | National University Hospital, SingaporeOTHER | 2 | Mar 29, 2018 | clinicaltrials |
| NCT03418207 | The Accuracy of Modified TTMB in the Spatial Distribution of Prostate Cancer | unknown | N/A | 50 | Subei People's Hospital of Jiangsu ProvinceOTHER | 1 | Mar 29, 2018 | clinicaltrials |
| NCT03468010 | A Trial Comparing Adjuvant Chemotherapy With Observation After Concurrent Chemoradiotherapy of Cervical Cancer (With Pelvic or Para-aortic Node Involvement) | unknown | Phase 3 | 432 | Sun Yat-sen UniversityOTHER | 1 | Mar 26, 2018 | clinicaltrials |
| NCT03477240 | Feasibility Study Of A Telephonic Questionnaire For Follow-Up Of Locally Advanced Cervical Cancer Patients | unknown | — | 300 | Tata Memorial HospitalOTHER_GOV | 0 | Mar 26, 2018 | clinicaltrials |
| NCT01650376 | Phase Ib Study of Olaparib Plus Weekly Carboplatin and Paclitaxel in Relapsed Ovarian Cancer | unknown | Phase 1 / Phase 2 | 52 | Swedish Medical CenterOTHER | 1 | Mar 23, 2018 | clinicaltrials |
| NCT03219385 | Directed Ablation of Uterine Fibroids Using a Noninvasive Approach(DIANA) | unknown | N/A | 180 | Mirabilis Medica, Inc.INDUSTRY | 0 | Mar 21, 2018 | clinicaltrials |
| NCT03439397 | RCT of Ballon Technique VS Selective Ophthalmic Artery Infusion For the Retinoblastoma Patients | unknown | N/A | 496 | Guangzhou Women and Children's Medical CenterOTHER | 0 | Mar 1, 2018 | clinicaltrials |
| NCT03450421 | Safety and Efficacy of Actamax™Adhesion Barrier in Women Undergoing Laparoscopic Abdominopelvic Surgery/Myomectomy | unknown | N/A | 152 | Actamax Surgical Materials LLCINDUSTRY | 0 | Mar 1, 2018 | clinicaltrials |
| NCT03076372 | A Study Evaluating MM-310 in Patients With Solid Tumors | unknown | Phase 1 | 34 | Merrimack PharmaceuticalsINDUSTRY | 1 | Feb 27, 2018 | clinicaltrials |
| NCT03446495 | An Observational Study of Combination of Pegylated Liposomal Doxorubicin and Trabectedin in Routine Practice in Patients With Recurrent Partial-platinum Sensitive Ovarian Cancer(Renaissance) | unknown | — | 60 | Suriya YessentayevaOTHER | 1 | Feb 26, 2018 | clinicaltrials |
| NCT02936258 | PRostate Evaluation for Clinically Important Disease: MRI vs Standard Evaluation Procedures(PRECISE) | unknown | N/A | 450 | Canadian Urology Research ConsortiumOTHER | 1 | Feb 22, 2018 | clinicaltrials |
| NCT00719303 | Diet and Physical Activity Change or Usual Care in Improving Progression-Free Survival in Patients With Previously Treated Stage II, III, or IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer | unknown | Phase 3 | 1,070 | Gynecologic Oncology GroupNETWORK | 1 | Feb 19, 2018 | clinicaltrials |
| NCT02534922 | Study of Prolanta™ in Recurrent or Persistent Epithelial Ovarian Cancer(ProlantaOC) | unknown | Phase 1 | 18 | Oncolix, Inc.INDUSTRY | 1 | Feb 14, 2018 | clinicaltrials |
| NCT03425240 | Intra-operative Neuromodulation of the Pelvic Plexus | unknown | N/A | 20 | Laikο General Hospital, AthensOTHER | 1 | Feb 8, 2018 | clinicaltrials |
| NCT02178462 | Biomarkers for Gynecologic Cancer | unknown | — | 153 | Ajinomoto Co., Inc.INDUSTRY | 1 | Jan 31, 2018 | clinicaltrials |
| NCT03180177 | Efficacy of HIPEC as NACT and Postoperative Chemotherapy in the Treatment of Advanced-Stage Epithelial Ovarian Cancer(EHNPCTASEOC) | unknown | Phase 3 | 263 | Shu-Zhong CuiOTHER | 1 | Jan 24, 2018 | clinicaltrials |
| NCT03406169 | Erectile Recovery After Robotic-Assisted Laparoscopic Prostatectomy | unknown | Phase 3 | 180 | Brooke Army Medical CenterFED | 1 | Jan 23, 2018 | clinicaltrials |
| NCT02322931 | C-arm Cone-beam CT in Prostate Brachytherapy(C-arm) | unknown | N/A | 35 | British Columbia Cancer AgencyOTHER | 1 | Jan 18, 2018 | clinicaltrials |
| NCT03196388 | Enzalutamide and External Beam Hypofractionated Radiotherapy For Intermediate Risk Localized Prostate Cancer(ENZART) | unknown | Phase 2 | 70 | Fundación Canaria Instituto de Investigación Sanitaria de CanariasOTHER | 1 | Jan 18, 2018 | clinicaltrials |
| NCT03403595 | 177Lu-EB-PSMA617 in Patients With Metastatic Castration-resistant Prostate Cancer | unknown | Phase 1 | 30 | Peking Union Medical College HospitalOTHER | 1 | Jan 18, 2018 | clinicaltrials |
| NCT03219242 | Primary Debulking Surgery Including Bowel Resection in Advanced Stage Ovarian Cancer Using Caiman® Technology(CAIMAN) | unknown | N/A | 40 | Catholic University of the Sacred HeartOTHER | 1 | Jan 16, 2018 | clinicaltrials |
| NCT03393507 | A Study of Apatinib Treatment in for Advanced Ovarian Cancer | unknown | Phase 2 | 34 | The People's Hospital of LeshanOTHER | 1 | Jan 16, 2018 | clinicaltrials |
| NCT03380741 | Lab-on-a-chip Detection of Cervical Cancer Tumour Markers(MODULAR) | unknown | — | 50 | Royal Marsden NHS Foundation TrustOTHER | 0 | Dec 21, 2017 | clinicaltrials |
| NCT03356912 | CABAzitaxel With or Without Prednisone in Patients With Metastatic CAstration REsistant Prostate Cancer Progressed During or After a Previous Docetaxel-based Chemotherapy | unknown | Phase 2 | 220 | Consorzio OncotechOTHER | 1 | Dec 14, 2017 | clinicaltrials |
| NCT02328716 | Cytoreduction With or Without Intraoperative Intraperitoneal Hyperthermic Chemotherapy (HIPEC) in Patients With Peritoneal Carcinomatosis From Ovarian Cancer, Fallopian Tube or Primary Peritoneal Carcinoma(CARCINOHIPEC) | unknown | Phase 3 | 32 | Fundacion para la Formacion e Investigacion Sanitarias de la Region de MurciaOTHER | 1 | Dec 13, 2017 | clinicaltrials |
| NCT03356444 | Docetaxel Versus Abiraterone as First-line Treatment in mCRPC Patients With Intraductal Carcinoma of the Prostate | unknown | Phase 2 | 140 | West China HospitalOTHER | 0 | Nov 29, 2017 | clinicaltrials |
| NCT03351088 | Outcomes From a RCT Comparing Preventive Versus Delayed Ligation of DVC During Robot-assisted Radical Prostatectomy | unknown | N/A | 226 | Azienda Socio Sanitaria Territoriale degli Spedali Civili di BresciaOTHER | 1 | Nov 22, 2017 | clinicaltrials |
| NCT03344822 | Place of 68Ga-PSMA-11 PET-CT in the Therapeutic Decision at the End of the Initial Staging for High Risk Prostate Cancer Patients(TePSMAG-68) | unknown | Phase 2 / Phase 3 | 33 | Central Hospital, Nancy, FranceOTHER | 1 | Nov 17, 2017 | clinicaltrials |
| NCT03335241 | Study of Fludarabine With Pegylated Liposomal Doxorubicin Versus Pegylated Liposomal Doxorubicin Alone In Patients With Platinum Resistant/Refractory Ovarian Cancer | unknown | Phase 2 | 140 | Sun Yat-sen UniversityOTHER | 1 | Nov 13, 2017 | clinicaltrials |
| NCT03332069 | Modulated Electro-Hyperthermia Plus Chemo-radiation for Locally Advanced Cervical Cancer Patients in South Africa(mEHT) | unknown | Phase 3 | 236 | Jeffrey KotzenOTHER | 1 | Nov 7, 2017 | clinicaltrials |
| NCT01853865 | Follow-up of Endometrial Cancer Patients(OPAL) | unknown | N/A | 211 | Odense University HospitalOTHER | 1 | Nov 6, 2017 | clinicaltrials |
| NCT02432365 | Study of Weekly Paclitaxel and Cisplatin in FIGO IB2 and IIA2 Cervical Cancer Followed by Radical Hysterectomy | unknown | Phase 2 | 64 | Chang Gung Memorial HospitalOTHER | 1 | Oct 30, 2017 | clinicaltrials |
| NCT03098160 | Immunotherapy Study of Evofosfamide in Combination With Ipilimumab | unknown | Phase 1 | 69 | Threshold PharmaceuticalsINDUSTRY | 1 | Oct 30, 2017 | clinicaltrials |
| NCT03321448 | TMTP1-ICG Mapping in Laparoscopic SLN Detection in Cervical Cancer | unknown | Phase 1 | 40 | Huazhong University of Science and TechnologyOTHER | 1 | Oct 27, 2017 | clinicaltrials |
Data updated 23 days agoSource updated Jun 6, 2018source: clinicaltrials